Not surprisingly, the molecular subtypes are closely associated with the main prognostic factors in GBM, IDH mutations and methylation of the promoter region of O6-methylguanine-DNA methyltransferase (MGMT) [21]. The gene discussed is IDH1; the disease is glioblastoma.